v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Total revenues $ 7,543 $ 17,073
Costs and operating expenses:    
Cost of product revenue 2,732 4,855
Research and development 12,942 11,246
Selling, general and administrative 12,355 12,860
Total costs and operating expenses 28,029 28,961
Loss from operations (20,486) (11,888)
Interest income 751 909
Interest and other expense, net (942) (516)
Loss before income taxes (20,677) (11,495)
Provision for income taxes 11 10
Net loss $ (20,688) $ (11,505)
Net loss per share, basic (in dollars per share) $ (0.25) $ (0.16)
Net loss per share, diluted (in dollars per share) $ (0.25) $ (0.16)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 82,410 69,854
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 82,410 69,854
Product revenue    
Revenues:    
Total revenues $ 6,059 $ 9,551
Research and development revenue    
Revenues:    
Total revenues $ 1,484 $ 7,522

Source